A Remarkable New Study Shows Stem Cells Can Reverse MS in Some Patients
January 15, 2019
(Vox) – The treatment is an experimental chemotherapy and hematopoietic stem cell transplant offered in the first randomized trial comparing the outcomes of patients receiving the treatment to patients who took standard MS medications. The results of the trial appeared Tuesday in the journal JAMA, and they are impressive: Among the 55 patients in the control group who took medication, 34 saw their disease worsen. But for the 55 (including Loy) who received the chemo and stem cell transplant, only three got worse. The rest saw their quality of life and disability improve.